SAN MARINO, Calif. -- Epeius Biotechnologies Corporation announced today that the company has received a Certificate of Product Registration for Rexin-G(R) from the Philippine Bureau of Food and Drugs (BFAD), enabling the commercialization of its lead product as a safe and effective treatment for a broad spectrum of intractable cancers.

BUFFALO GROVE, Ill. -- The internal medicine / family practice medical group practices formerly named Greater Northwest Medical Group, North Suburban Internists and Adult Care Specialists have merged to become Affinity Healthcare, LLC.

STERLING HEIGHTS, Mich. -- Accents Cosmetic Surgery & Medical Spa in Sterling Heights, Michigan has become the first Detroit-based Medical Spa to offer an exclusive VIP membership program. Dozens of men and women have already signed up and committed to caring for this skin and addressing their cosmetic flaws in 2008. The beauty of this program is that it allows Michiganders to enjoy the benefits of a medical spa at a tremendous savings.

SAN MARINO, Calif. -- Epeius Biotechnologies Corporation announced today that the company has taken a major step toward the commercialization of its lead product with the opening of a Phase II Registration Protocol using Rexin-G for osteosarcoma in the United States. Following the accelerated approval of Rexin-G for the treatment of all solid tumors by the Bureau of Food and Drugs in the Philippines, Epeius opened a number of Phase I/II clinical trials.

SAN MARINO, Calif. and BOSTON, Mass. -- Epeius Biotechnologies Corporation today announced that Dr. Frederick L. Hall, President and CEO of Epeius Biotechnologies Inc., has accepted an invitation to give the lead keynote address on "The Advent of Pathotropic Medicine for Cancer" at the Global Pharma R&D Summit 2007 to be held in Boston MA. On October 22, 2007 at 8:00 a.m., Dr. Hall will present the scientific principles, the clinical validation, and global development status.

PEORIA, Ill. -- The Sher Institutes for Reproductive Medicine (SIRM(TM)) have announced that Dr. Milton McNichol will assume the role of Medical Director of SIRM-Central Illinois, located in Peoria. Dr. McNichol is a board certified Reproductive Endocrinologist who joins SIRM-Central Illinois from an infertility practice in Shawnee Mission, Kansas.

RICHMOND, Texas -- CYNACON / OCuSOFT (OCuSOFT, Inc.), a company specializing in ophthalmic research, development and supply to ophthalmologists and optometrists, is pleased to announce the appointment of Katherine Mastrota, M.S., O.D., to its Optometric Scientific Advisory Board.

MOUNT VERNON, Wash. -- PreViser Corporation, a world leader in risk and disease analysis software that enhances treatment planning for patients affected by oral disease, announced a simultaneous release of a new corporate website and a major upgrade to its software.

SAN FRANCISCO, Calif. -- California Kidney Cancer Foundation Executive Director, Dr. David Minor will present a review of treatments for metastatic kidney cancer as presented at the most recent American Society of Clinical Oncology Conference. The presentation will be from 3 to 5 PM on September 15, 2007 at California Pacific Medical Center.

RICHMOND, Texas -- CYNACON / OCuSOFT (OCuSOFT, Inc.), a company specializing in ophthalmic research, development and supply to ophthalmologists and optometrists, is pleased to announce the appointment of Edward J. Holland, M.D. to its Medical Scientific Advisory Board.